Plasma renin predicts success of antihypertensive drug withdrawal

Gloria Y F Ho, M. Donald Blaufox, Sylvia Wassertheil-Smoller, Albert Oberman, Herbert Langford

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This study examined the relationship of plasma renin activity (PRA) to the likelihood of maintaining blood pressure control after discontinuation of antihypertensive medication. Patients whose blood pressure was previously treated and controlled in the Hypertension Detection and Follow-up Program were enrolled in the Dietary Intervention Study of Hypertension. After stratification by obesity, patients were randomized to discontinue medication with no dietary intervention, sodium restriction, or weight reduction for the obese. Among 496 subjects in the Dietary Intervention Study of Hypertension, 75 were randomly selected for PRA measurement at 4 months after intervention, and all had their blood pressure under conkol at that time. Patients were followed up for 56 weeks after randomization. The endpoint was return to antihypertensive medication due to elevated diastolic blood pressure. Kaplan-Meier survival analysis showed that subjects with PRA ≤ 53.3 ng/100 mL/h, the median level, had a lower cumulative success rate for remaining off antihypertensive drug than those with PRA above the median (P = .046). In Cox regression analysis controlling for 24-h urinary sodium level, baseline diastolic blood pressure, age, sex, race, obesity, and dietary intervention group, a unit decrease in log PRA was associated with a 2.78-fold increase in risk of returning to drug (P = .006); this inverse relationship was independent of dietary intervention and change in diastolic blood pressure in the first 4 months before PRA was measured. The data indicate that patients with low PRA are less likely to maintain blood pressure control without drugs than patients with high PRA.

Original languageEnglish (US)
Pages (from-to)679-684
Number of pages6
JournalAmerican Journal of Hypertension
Volume7
Issue number8
StatePublished - Aug 1994

Fingerprint

Renin
Antihypertensive Agents
Blood Pressure
Hypertension
Obesity
Dietary Sodium
Drug and Narcotic Control
Kaplan-Meier Estimate
Survival Analysis
Random Allocation
Weight Loss
Sodium
Regression Analysis

Keywords

  • blood pressure control
  • drug therapy
  • hypertension
  • Renin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ho, G. Y. F., Blaufox, M. D., Wassertheil-Smoller, S., Oberman, A., & Langford, H. (1994). Plasma renin predicts success of antihypertensive drug withdrawal. American Journal of Hypertension, 7(8), 679-684.

Plasma renin predicts success of antihypertensive drug withdrawal. / Ho, Gloria Y F; Blaufox, M. Donald; Wassertheil-Smoller, Sylvia; Oberman, Albert; Langford, Herbert.

In: American Journal of Hypertension, Vol. 7, No. 8, 08.1994, p. 679-684.

Research output: Contribution to journalArticle

Ho, GYF, Blaufox, MD, Wassertheil-Smoller, S, Oberman, A & Langford, H 1994, 'Plasma renin predicts success of antihypertensive drug withdrawal', American Journal of Hypertension, vol. 7, no. 8, pp. 679-684.
Ho GYF, Blaufox MD, Wassertheil-Smoller S, Oberman A, Langford H. Plasma renin predicts success of antihypertensive drug withdrawal. American Journal of Hypertension. 1994 Aug;7(8):679-684.
Ho, Gloria Y F ; Blaufox, M. Donald ; Wassertheil-Smoller, Sylvia ; Oberman, Albert ; Langford, Herbert. / Plasma renin predicts success of antihypertensive drug withdrawal. In: American Journal of Hypertension. 1994 ; Vol. 7, No. 8. pp. 679-684.
@article{067257bd49e04bfb864c442b5c528204,
title = "Plasma renin predicts success of antihypertensive drug withdrawal",
abstract = "This study examined the relationship of plasma renin activity (PRA) to the likelihood of maintaining blood pressure control after discontinuation of antihypertensive medication. Patients whose blood pressure was previously treated and controlled in the Hypertension Detection and Follow-up Program were enrolled in the Dietary Intervention Study of Hypertension. After stratification by obesity, patients were randomized to discontinue medication with no dietary intervention, sodium restriction, or weight reduction for the obese. Among 496 subjects in the Dietary Intervention Study of Hypertension, 75 were randomly selected for PRA measurement at 4 months after intervention, and all had their blood pressure under conkol at that time. Patients were followed up for 56 weeks after randomization. The endpoint was return to antihypertensive medication due to elevated diastolic blood pressure. Kaplan-Meier survival analysis showed that subjects with PRA ≤ 53.3 ng/100 mL/h, the median level, had a lower cumulative success rate for remaining off antihypertensive drug than those with PRA above the median (P = .046). In Cox regression analysis controlling for 24-h urinary sodium level, baseline diastolic blood pressure, age, sex, race, obesity, and dietary intervention group, a unit decrease in log PRA was associated with a 2.78-fold increase in risk of returning to drug (P = .006); this inverse relationship was independent of dietary intervention and change in diastolic blood pressure in the first 4 months before PRA was measured. The data indicate that patients with low PRA are less likely to maintain blood pressure control without drugs than patients with high PRA.",
keywords = "blood pressure control, drug therapy, hypertension, Renin",
author = "Ho, {Gloria Y F} and Blaufox, {M. Donald} and Sylvia Wassertheil-Smoller and Albert Oberman and Herbert Langford",
year = "1994",
month = "8",
language = "English (US)",
volume = "7",
pages = "679--684",
journal = "Journal of clinical hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Plasma renin predicts success of antihypertensive drug withdrawal

AU - Ho, Gloria Y F

AU - Blaufox, M. Donald

AU - Wassertheil-Smoller, Sylvia

AU - Oberman, Albert

AU - Langford, Herbert

PY - 1994/8

Y1 - 1994/8

N2 - This study examined the relationship of plasma renin activity (PRA) to the likelihood of maintaining blood pressure control after discontinuation of antihypertensive medication. Patients whose blood pressure was previously treated and controlled in the Hypertension Detection and Follow-up Program were enrolled in the Dietary Intervention Study of Hypertension. After stratification by obesity, patients were randomized to discontinue medication with no dietary intervention, sodium restriction, or weight reduction for the obese. Among 496 subjects in the Dietary Intervention Study of Hypertension, 75 were randomly selected for PRA measurement at 4 months after intervention, and all had their blood pressure under conkol at that time. Patients were followed up for 56 weeks after randomization. The endpoint was return to antihypertensive medication due to elevated diastolic blood pressure. Kaplan-Meier survival analysis showed that subjects with PRA ≤ 53.3 ng/100 mL/h, the median level, had a lower cumulative success rate for remaining off antihypertensive drug than those with PRA above the median (P = .046). In Cox regression analysis controlling for 24-h urinary sodium level, baseline diastolic blood pressure, age, sex, race, obesity, and dietary intervention group, a unit decrease in log PRA was associated with a 2.78-fold increase in risk of returning to drug (P = .006); this inverse relationship was independent of dietary intervention and change in diastolic blood pressure in the first 4 months before PRA was measured. The data indicate that patients with low PRA are less likely to maintain blood pressure control without drugs than patients with high PRA.

AB - This study examined the relationship of plasma renin activity (PRA) to the likelihood of maintaining blood pressure control after discontinuation of antihypertensive medication. Patients whose blood pressure was previously treated and controlled in the Hypertension Detection and Follow-up Program were enrolled in the Dietary Intervention Study of Hypertension. After stratification by obesity, patients were randomized to discontinue medication with no dietary intervention, sodium restriction, or weight reduction for the obese. Among 496 subjects in the Dietary Intervention Study of Hypertension, 75 were randomly selected for PRA measurement at 4 months after intervention, and all had their blood pressure under conkol at that time. Patients were followed up for 56 weeks after randomization. The endpoint was return to antihypertensive medication due to elevated diastolic blood pressure. Kaplan-Meier survival analysis showed that subjects with PRA ≤ 53.3 ng/100 mL/h, the median level, had a lower cumulative success rate for remaining off antihypertensive drug than those with PRA above the median (P = .046). In Cox regression analysis controlling for 24-h urinary sodium level, baseline diastolic blood pressure, age, sex, race, obesity, and dietary intervention group, a unit decrease in log PRA was associated with a 2.78-fold increase in risk of returning to drug (P = .006); this inverse relationship was independent of dietary intervention and change in diastolic blood pressure in the first 4 months before PRA was measured. The data indicate that patients with low PRA are less likely to maintain blood pressure control without drugs than patients with high PRA.

KW - blood pressure control

KW - drug therapy

KW - hypertension

KW - Renin

UR - http://www.scopus.com/inward/record.url?scp=0027937527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027937527&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 679

EP - 684

JO - Journal of clinical hypertension

JF - Journal of clinical hypertension

SN - 0895-7061

IS - 8

ER -